诱导性放松增强了COVID-19幸存者的心肺呼吸系统动态
Alejandra Margarita Sánchez-Solís1, Viridiana Peláez-Hernández2, Laura Mercedes Santiago-Fuentes1,3
1School of Medicine, Universidad Autónoma del Estado de México (UAEMéx), Toluca de Lerdo 50180, Mexico.
Entropy (Basel, Switzerland)
|June 28, 2023
概括
慢节奏呼吸练习显示出改善COVID-19幸存者的心肺呼吸动态的希望. 这种技术增强了心肺呼吸系统的合,可能有助于从持续的症状中恢复,例如交感管失衡.
科学领域:
- 心血管呼吸系统生理学
- 后COVID条件 后COVID条件
- 自主神经系统功能 自主神经系统功能
背景情况:
- 许多COVID-19幸存者经历了持续的症状,包括交感管不平衡,影响整体健康.
- 慢节奏呼吸 (SPB) 是一种已知的技术,可以改善各种人群的心血管和呼吸系统调节.
研究的目的:
- 研究SPB对COVID-19幸存者的心肺呼吸系统动态的影响.
- 用线性和非线性方法分析呼吸速率变化率 (BRV),脉冲速率变化率 (PRV) 和脉冲-呼吸量 (PRQ).
主要方法:
- 在心理生理学评估期间,分析了49名COVID-19幸存者的光电脉冲和呼吸信号.
- 应用线性和非线性分析来评估SPB和隔膜呼吸期间的BRV,PRV和PRQ.
- 进行了基于并发症的子组分析.
主要成果:
- SPB显著改变了所有BRV指数.
- 非线性PRV参数比线性指数对呼吸模式变化更敏感.
- 隔膜呼吸导致PRQ增加和PRV (样本和模糊) 降低,表明心肺呼吸器合增强.
结论:
- SPB证明了COVID-19幸存者的心肺呼吸系统动态的短期益处.
- 这种技术似乎可以改善心肺呼吸系统的合,可能是通过增加阴道活动.
- 需要进一步研究SPB作为COVID-19后疾病的辅助疗法.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
COPD: Pathogenesis and Clinical Features
365
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
365
Respiratory Capacities
850
Respiratory capacities are crucial indicators of lung function, representing the maximum amount of air an individual's respiratory system can handle during various breathing phases.
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
850
Acute Respiratory Failure-II
285
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
285
Acute Respiratory Failure-III
232
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
232
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K


